Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis

Introduction: Recently, cystic fibrosis transmembrane regulator modulator therapy with elexacaftor/tezacaftor/ivacaftor has become available for children with cystic fibrosis (CF) carrying at least one F508del mutation. Objective: To assess the intermediate term effects of elexacaftor/tezacaftor/iva...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier, Margarete, Kavvalou, Alexandra, Welsner, Matthias, Hirtz, Raphael, Straßburg, Svenja, Sutharsan, Sivagurunathan, Stehling, Florian, Steindor, Mathis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203630/
https://www.ncbi.nlm.nih.gov/pubmed/37229253
http://dx.doi.org/10.3389/fphar.2023.1176815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203630/
https://www.ncbi.nlm.nih.gov/pubmed/37229253
http://dx.doi.org/10.3389/fphar.2023.1176815

Ejemplares similares